These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3603105)

  • 21. Cutaneous vasculitis associated with pheochromocytoma.
    Kulp-Shorten CL; Rhodes RH; Peterson H; Callen JP
    Arthritis Rheum; 1990 Dec; 33(12):1852-6. PubMed ID: 2261006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.
    Zhu KJ; Yang PD; Xu Q
    Front Immunol; 2021; 12():695768. PubMed ID: 34248994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
    Micheletti RG; Pagnoux C; Tamura RN; Grayson PC; McAlear CA; Borchin R; Krischer JP; Merkel PA;
    Trials; 2020 Apr; 21(1):362. PubMed ID: 32345372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypocomplementaemic urticarial vasculitis with bullous lesions and pericardial involvement].
    Kervarrec T; Binois R; Bléchet C; Estève É
    Ann Dermatol Venereol; 2015 Oct; 142(10):557-62. PubMed ID: 25613197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma-induced local leukocytoclastic vasculitis at the subcutaneous injection site.
    Wang F; Liu JH; Zhao YK; Luo DQ
    An Bras Dermatol; 2016; 91(5 suppl 1):76-78. PubMed ID: 28300901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
    Batioğlu F; Taner P; Aydintuğ OT; Heper AO; Ozmert E
    Cutan Ocul Toxicol; 2006; 25(4):281-5. PubMed ID: 17162415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and immunopathologic features of idiopathic cutaneous immunoglobulin M/G vasculitis versus idiopathic skin-limited immunoglobulin A vasculitis.
    Marzano AV; Genovese G; Tavecchio S; Germiniasi F; Fanoni D; Caproni M; Ortega-Loayza A
    J Am Acad Dermatol; 2021 Jan; 84(1):175-178. PubMed ID: 32334061
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukocytoclastic vasculitis in subacute cutaneous lupus erythematosus: clinicopathologic study of three cases and review of the literature.
    Sánchez-Pérez J; Peñas PF; Ríos-Buceta L; Fernández-Herrera J; Fraga J; García-Díez A
    Dermatology; 1996; 193(3):230-5. PubMed ID: 8944346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urticarial vasculitis: a report of nine cases and review of the literature.
    Callen JP; Kalbfleisch S
    Br J Dermatol; 1982 Jul; 107(1):87-93. PubMed ID: 7104212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urticarial vasculitis.
    Chang S; Carr W
    Allergy Asthma Proc; 2007; 28(1):97-100. PubMed ID: 17390766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case report.
    Eiser AR; Singh P; Shanies HM
    Angiology; 1997 Nov; 48(11):1019-22. PubMed ID: 9373057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leukocytoclastic vasculitis: a response to treatment with sulfone].
    Revenga Arranz F; Gonzalo Garijo MA
    An Med Interna; 1999 Jan; 16(1):51. PubMed ID: 10089657
    [No Abstract]   [Full Text] [Related]  

  • 33. [Leukocytoclastic vasculitis].
    Sunderkötter C; Roth J; Bonsmann G
    Hautarzt; 2004 Aug; 55(8):759-83; quiz 784-5. PubMed ID: 15257403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic strategies in ANCA-associated systemic vasculitis].
    Ruiz FL; Bart PA
    Rev Med Suisse; 2005 Jan; 1(1):19-23. PubMed ID: 15773192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary hemosiderosis with normocomplementemic urticarial vasculitis in a child.
    Yuksel H; Yilmaz O; Savas R; Kirmaz C; Sogut A; Ozalp S
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):63-6. PubMed ID: 17564286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical approach to cutaneous vasculitis.
    Chen KR; Carlson JA
    Am J Clin Dermatol; 2008; 9(2):71-92. PubMed ID: 18284262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Necrotizing cutaneous vasculitis with massive gastrointestinal bleeding following naproxen treatment].
    Horev A; Etzion O; Halevy S
    Harefuah; 2010 Mar; 149(3):157-60, 195, 194. PubMed ID: 20684166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urticarial vasculitis].
    Doutre MS
    Allerg Immunol (Paris); 1998 Apr; 30(4):99-100, 103. PubMed ID: 9631690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide therapy of severe systemic necrotizing vasculitis.
    Fauci AS; Katz P; Haynes BF; Wolff SM
    N Engl J Med; 1979 Aug; 301(5):235-8. PubMed ID: 36563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.
    Kawakami T
    J Dermatol; 2010 Feb; 37(2):113-24. PubMed ID: 20175844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.